Thirugnana Sambandam Sneha, Dominic Dobson, Ravi Praveen, Jadhav Ashirwad
Sports Medicine, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, IND.
Cureus. 2024 Sep 23;16(9):e70059. doi: 10.7759/cureus.70059. eCollection 2024 Sep.
This case study explores the use of super-dose platelet-rich plasma (PRP) in managing a meniscal tear in a 43-year-old woman with left knee pain. The patient was diagnosed with a vertical longitudinal tear of the body and posterior horn medial meniscus, confirmed through magnetic resonance imaging. Super-dose PRP, characterized by a higher platelet volume (8 ml), was administered intra-articular. Post-injection, the patient reported initial discomfort for a few days, but significant improvements in pain and range of motion (ROM) were observed within the first week. Over 12 weeks, her visual analog scale pain score decreased from 8/10 during activity to 2/10, and her ROM returned to full functionality. The case supports the hypothesis that super-dose PRP may enhance the healing process in meniscal injuries by promoting tissue healing and regeneration through the release of growth factors, angiogenesis, collagen synthesis, and inflammation modulation. This case highlights PRP's potential as a non-surgical treatment for meniscal tears. Further large-scale studies and randomized controlled trials are needed to validate these results, optimize dosing strategies, and determine which patient populations will benefit most from this innovative treatment approach.
本病例研究探讨了使用超大剂量富血小板血浆(PRP)治疗一名43岁左膝疼痛女性的半月板撕裂。患者经磁共振成像确诊为内侧半月板体部和后角垂直纵向撕裂。超大剂量PRP的特点是血小板体积更高(8毫升),通过关节内注射给药。注射后,患者报告最初几天有不适,但在第一周内疼痛和活动范围(ROM)有显著改善。在12周的时间里,她的视觉模拟评分疼痛评分从活动时的8/10降至2/10,并且她的ROM恢复到完全功能。该病例支持这样的假设,即超大剂量PRP可能通过释放生长因子、促进血管生成、胶原蛋白合成和调节炎症来促进组织愈合和再生,从而增强半月板损伤的愈合过程。该病例突出了PRP作为半月板撕裂非手术治疗方法的潜力。需要进一步的大规模研究和随机对照试验来验证这些结果,优化给药策略,并确定哪些患者群体将从这种创新治疗方法中获益最大。